SPONSORED CONTENT The evolving landscape of pharmaceutical pricing and reimbursement models presents complex challenges for manufacturers and pharmacies. One of […]
SPONSORED CONTENT It’s January, which means we’ve released our Top Ten Issues for 2025! The experts at Visante have provided […]
SPONSORED CONTENT Join Apexus at an upcoming webinar, Resolving 340B Noncompliance: From Reversals to Refunds, on Wednesday, January 15. This […]
SPONSORED CONTENT The 340B Drug Pricing Program offers significant savings to eligible healthcare organizations, enabling them to stretch scarce resources […]
SPONSORED CONTENT You’ve assessed your 340B program, identified compliance concerns, and incorporated necessary corrective actions into your 340B program operations. […]
SPONSORED CONTENT The 340B program continues to be a central topic of discussion in the pharmaceutical landscape, especially as specialty […]
SPONSORED CONTENT Imagine the services you could offer to the community your facility serves if you had additional funding. If […]
SPONSORED CONTENT We understand that referrals are often the grayest area of your 340B program. That’s why we’ve been building […]
SPONSORED CONTENT Introduction In today’s evolving healthcare landscape, pharmacy reconciliation has become much more than a routine accounting task—it has […]
SPONSORED CONTENT Understanding Provider Panels Provider panels are lists used by 340B Third-Party Administrators (TPAs) to determine which providers’ claims […]